Site-specific N-glycoproteomic analysis of extracellular vesicles from seminal plasma reveals the molecular typing of azoospermia
Azoospermia, a severe form of male infertility, lacks non-invasive diagnostic tools for molecular typing. Glycosylation of extracellular vesicles (EVs) has diagnostic potential in various diseases. However, high-sensitivity analysis of EV site-specific N-glycans remains challenging, particularly from microliter biofluids. Here, we develop EVGlyco, an integrated low-input workflow for site-specific N-glycans analysis of EV proteins. EVGlyco yields more intact N-glycopeptide identifications than ultracentrifugation-based workflows and is applicable to seven human biofluids. From seminal plasma, 8,435 EV protein site-specific N-glycans are identified in the discovery cohort, and targeted validation via parallel reaction monitoring (PRM) confirms the panel of MPO-N355-H6N2 and ACP3-N94-H5N4F1 distinguishing obstructive azoospermia (OA) from nonobstructive azoospermia (NOA) with an area under the curve (AUC) of 0.88, while CLU-N374-H10N9 and CLU-N374-H10N9F1 further accurately distinguish three NOA subtypes (hypospermatogenesis: 0.86, maturation arrest: 0.99, and Sertoli cell-only: 0.87). This study supports EV protein site-specific N-glycans as diagnostic signatures for non-invasive molecular typing of azoospermia. This study presents EVGlyco, a low-input platform for site-specific N-glycoproteomic analysis of biofluid EVs. It identifies site-specific N-glycan signatures in seminal plasma EVs that distinguish azoospermia types and nonobstructive subtypes.
Authors
- Yulian Wang (ORCID: https://orcid.org/0000-0001-8721-0876)
- Zhongze Gu (ORCID: https://orcid.org/0000-0001-8926-7710)
- Zhuoying Xie (ORCID: https://orcid.org/0000-0003-3534-1924)
- Xuejiang Guo (ORCID: https://orcid.org/0000-0002-0475-5705)
- Yueshuai Guo (ORCID: https://orcid.org/0000-0002-2719-1244)
- Hui Jiang (ORCID: https://orcid.org/0000-0002-6256-2733)
- Haixia Tu
- Xiaorong Song
- Xiangzheng Zhang (ORCID: https://orcid.org/0009-0001-8223-151X)
- Yue Wang (ORCID: https://orcid.org/0000-0002-7670-7673)
- Yan Li (ORCID: https://orcid.org/0000-0003-0420-4222)
- Bing Wang (ORCID: https://orcid.org/0000-0003-0684-2789)
- Zhe Zhang (ORCID: https://orcid.org/0000-0003-2365-2362)
- Yifan Zhou (ORCID: https://orcid.org/0000-0002-1811-9216)
- Xiaoyu Yang (ORCID: https://orcid.org/0000-0002-6411-8935)
- Yifei Deng (ORCID: https://orcid.org/0009-0005-1530-1273)
- Mingyang Li (ORCID: https://orcid.org/0000-0001-7723-951X)
- Dong Wei
- Jie Ni (ORCID: https://orcid.org/0009-0003-9767-5441)
- Yuhan Cai (ORCID: https://orcid.org/0009-0009-4750-9246)
- Tianye Wang
- Xiang Li
- Xinyu Wang
- Jie Sun
- Zibing Han
- Nan Lu
Institutions
- Fujian Medical University (CN)
- Peking University (CN)
- Peking University First Hospital (CN)
- Peking University Third Hospital (CN)
- State Key Laboratory of Digital Medical Engineering (CN)
- State Key Laboratory of Reproductive Medicine (CN)
- Southeast University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1038/s41467-026-79570-x
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00